intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Systole Health Launches Innovative Virtual Group Health Care for Women’s Heart Health with $2M Pre-Seed Funding Round Led by Benchstrength

Systole Health Launches Innovative Virtual Group Health Care for Women’s Heart Health with $2M Pre-Seed Funding Round Led by Benchstrength

February 7, 2025 Craig Etkin

New Women’s Heart Health-Focused Service Aims to Solve Physician Access Crisis with Innovative Group Virtual Care Solution

BOSTON, Jan. 27, 2025 /PRNewswire/ — Systole Health, a tech-enabled group virtual care solution for women’s heart health, today announced $2M in pre-seed funding. The round was led by Benchstrength, with participation from January Ventures, J Ventures, and Tom X. Lee, founder of One Medical.

Systole Health delivers comprehensive care for women’s heart health through innovative group virtual visits. Women at risk for heart disease meet with a doctor and health coach to receive personalized coaching, medical care, and a supportive community in hour-long appointments. This program is a proven, yet underused, group care model that offers women the opportunity to ask questions and get expert care and support. By comparison, the current average doctor-patient visit is 18 minutes, primarily focused on medication management, an issue compounded by physician shortages and accessibility challenges as patient volumes continue to increase. Systole Health is available directly to consumers and will become available through partnering health systems as the program expands.

Heart disease is the leading cause of death among women, with 90% of women having at least one heart disease risk factor and 45% already carrying diagnoses of cardiovascular disease (CVD). Despite these alarming statistics, women are underdiagnosed and undertreated for heart disease risk factors.

“When we look at investments, we prioritize new companies that address an unmet need with a novel approach, brought to us by founders who have both vision and a distinct ability to execute,” said Ken Chenault Jr., Managing Partner at Benchstrength. “Systole Health meets all these criteria with its innovative group virtual care model, which leverages technology to provide scalable and sustainable solutions for women’s heart health. Their patient-first approach, designed specifically to address systemic gaps in cardiovascular care for women, is transformative, and we’re excited to support their mission to deliver meaningful outcomes and expand access to quality care.”

Dr. Simin Lee, CEO and founder of Systole Health notes, “Our mission is to bend the curve of heart disease in women by introducing a new care model that prioritizes outcomes and connection. As a cardiologist, I have witnessed firsthand the struggles women face in managing their heart health. Our solution is built for women by women, addressing the unique challenges we experience and expanding access to the kind of care we want for our mothers, aunts, sisters, and daughters.”

Lauren McConnell, COO and founder of Systole Health adds, “We know there’s a lot of women looking for help with their heart health, without the option to get into their existing providers as much as they need to. I’m excited to build a supportive, community-driven space for those women, extending their lives and by extension – improving the health of their families.”

Systole Health plans to utilize the funding to expand into key markets throughout the United States and build its early clinical team. The company is also focused on forming strategic partnerships with healthcare providers and payers to further integrate its services into the broader healthcare ecosystem. Currently, the program is being piloted and serving patients in Massachusetts and Florida.

“At Systole Health, we’ve seen how this model can do more with less and unlock the power of community for our patients,” says Dr. Lee. “This is exactly the kind of solution needed to truly move the needle for women’s heart health.”

About Systole Health

Based in Boston, Systole Health is a pre-seed start-up revolutionizing women’s heart health through its innovative, tech-enabled group virtual care model. Focused on addressing systemic gaps in cardiovascular care, Systole Health delivers scalable, community-driven solutions that prioritize access, outcomes, and patient connection. Led by Dr. Simin Gharib Lee, a Harvard-trained cardiologist, and Lauren McConnell, a digital health innovator, the company is backed by Benchstrength, January Ventures, J Ventures, and Tom X. Lee. For more information, visit www.systolehealth.com.

Media Contact: 

Vikki Herrera
Oak Street Communications for Systole Health
vikki@oakstreetcommunications.com

SOURCE Systole Health

Copyright © 2025 Cision US Inc.


Venture Capital
Boston, Cision, Massachusetts, PRNewswire`, Systole Health, Venture Capital

Post navigation

NEXT
Earth AI Closes Oversubscribed Round; Raising $20M for AI Driven Mineral Exploration
PREVIOUS
Trinity Capital Inc. Provides $30 Million in Growth Capital to Elucent Medical
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Kimberly-Clark Corporation, one of the world's leading manufacturers of personal care and hygiene products, will establish an $800 million advanced manufacturing facility in Trumbull County, bringing an anticipated 491 new high-quality jobs. For Kimberly-Clark, this new facility would be its first in Ohio and represents not just a strategic expansion, but a decisive step in doubling down on growth in the American market. Spread across more than one million square feet, the Warren facility will provide the manufacturing capacity needed to unleash future growth for Kimberly-Clark’s fastest-growing personal care categories that include Baby & Child Care and Adult & Feminine Care. Warren is in geographic proximity to roughly 117 million consumers and will serve as a strategic hub for the Northeast and Midwest regions. Construction is expected to begin this month and will take up to two years.

In a statement Tamera Fenske, chief supply chain officer at Kimberly-Clark said, “Our investment in Warren is a pivotal step forward in our North America business and strategy.” “By establishing a new, state-of-the-art manufacturing facility in Ohio, we’re enhancing our ability to serve millions of consumers across the Midwest and Northeast with greater speed, agility, and resilience. It’s a once-in-a-career opportunity to build a facility from the ground up that reflects the future of manufacturing, and with the support of local partners like JobsOhio, the Department of Development, Lake to River, Western Reserve Port Authority, and local governments, we have the unique opportunity to create high-quality jobs and long-term economic impact in the region.”

Based in Dallas and employing 46,000 people in 34 countries, the company’s portfolio of brands also includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll. Its products are sold in more than 175 countries and territories.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its mission to turn knowledge into specialized AI—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. In addition, Snorkel AI announced it has raised $100 million in Series D funding at a $1.3 billion valuation, led by Addition. This new funding will fuel continued research and innovation in evaluating and tuning specialized AI systems with expert data.


In a statement Alex Ratner, Co-founder and CEO of Snorkel AI said, “We are seeing a surge of momentum around agentic AI, but specialized enterprise agents aren’t ready for production in most settings.” “Enterprises need domain-specific data and expertise to make this a reality. We’re excited to deliver on this need and help AI innovators develop expert data to bring their LLM and agentic systems into production with our new offerings, which round out Snorkel’s unified AI data development stack.”

Snorkel AI is building the Snorkel AI Data Development Platform for evaluating and tuning specialized AI at scale. Snorkel AI’s offerings, including Snorkel Evaluate and Snorkel Expert Data-as-a-Service, accelerate evaluation and tuning of specialized AI systems with expert data—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. Launched out of the Stanford AI Lab, Snorkel AI’s platform is used in production by Fortune 500 companies, including BNY, Wayfair, and Chubb, as well as across the U.S. federal government, including the U.S. Air Force.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

TicketManager, a global leader in event ticket and guest management solutions for the corporate enterprise, today announced Valeas Capital Partners, a growth-oriented private-equity firm, has acquired a majority stake in the company. Under the terms of the agreement, Valeas is committing $110 million to support TicketManager’s strategic growth plans. TicketManager Co-Founder and CEO Tony Knopp and COO Ken Hanscom will retain a minority interest in the Company. Founded in 2007, TicketManager is the category leader in providing software and services to manage end-to-end event ticket workflow and guest experiences. Serving as the central hub and system of record for data-driven organizations, the platform streamlines every step of the ticket management process. Every year, companies spend more than $600 billion on customer entertainment, yet 43% of corporate tickets are never used and fewer than 20% of organizations leverage modern software to optimize those investments and mitigate compliance risk.

In a statement Tony Knopp, CEO and Co-Founder of TicketManager said, “Live events are an important investment for businesses of all sizes. Whether major global sponsorships, naming rights for stadiums, luxury suites or even a few season tickets for the local team, companies use them to attract and keep customers while building their brands. But in today’s market, many companies struggle with growing pressure to show the value of their ticket spending.” “We knew there was a better way, and that’s why we created TicketManager – to make company tickets easy and prove the return on investment with cutting edge technology and services.”

TicketManager is a leading event- and guest-management platform that empowers companies to make client entertainment easy and drive greater return on investment. It offers convenient and simple technology to manage corporate sports and entertainment tickets, create exceptional guest life-cycle experiences, and measure effectiveness. TicketManager is trusted by more than 500 global brands including Verizon, FedEx, Adidas, Anheuser-Busch, and Mastercard.
Load More... Subscribe

Categories

Recent Posts

  • Bespoken Spirits Announces Successful Close of Series-C Funding Round June 9, 2025
  • Bito Raises $5.7M Seed Extension to Expand AI Code Review Platform with Codebase Awareness June 9, 2025
  • Pillar Biosciences Raises $34.5M in Funding June 9, 2025
  • CloudZero Raises $56M Series C To Redefine Cloud Cost Optimization In The AI Era June 9, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.